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Abstract. By applying recent results in optimization transfer, a new al-
gorithm for kernel Fisher Discriminant Analysis is provided that makes
use of a non-smooth penalty on the coefficients to provide a parsimo-
nious solution. The algorithm is simple, easily programmed and is shown
to perform as well as or better than a number of leading machine learning
algorithms on a substantial benchmark. It is then applied to a set of ex-
treme small-sample-size problems in virtual screening where it is found to
be less accurate than a currently leading approach but is still comparable
in a number of cases.
1 Introduction
Fisher discriminant analysis has a central role in pattern recognition. It seeks
a linear projection that maximizes the separation between data belonging to
two classes while minimizing the separation between those of the same class.
Its properties are well-documented and under certain circumstances prove opti-
mal [1]. However, the linearity of the approach is frequently insufficient to allow
the required level of performance in practical applications. While explicit expan-
sion of data in basis functions can resolve this for problems of low dimension,
the combinatorial increase in the number of coefficients to be estimated may
make this impractical. Recent focus on kernel machines in the machine learning
community seeks to address this problem via the so-called “kernel trick” [2] and
a number solutions have been provided e.g. [3] that can be thought of generically
as kernel Fisher discriminant analysis (kFDA). While kernels lend the required
degree of flexibility to the discrimination task, they bring their own challenges,
the foremost being a potential to overspecialize to the sample data (over-fitting)
and a computational complexity dominated by sample size which, in some prob-
lems, may be large. Complexity control is therefore essential for a good outcome
yet it has not been widely explored in the context of kFDA. In [3] complexity
is controlled through explicit regularization – placing an appropriate penalty on
the coefficients of the estimator, while [4] exploits the connection between FDA
and an associated least-squares (LS) problem where an orthogonalization tech-
nique is used for forward selection. In benchmarks, the latter technique is seen to
be competitive with a number of leading machine-learning classifiers including
kFDA while providing more parsimonious estimators.
The motivation for our work lies in the field of chemoinformatics, in particu-
lar in virtual screening. Virtual screening (VS) describes a set of computational
methods that provide a fast and cheap alternative to biological screening which
involves the selection, synthesis and testing of molecules to ascertain their bio-
logical activity in a particular domain, e.g. pain relief, reduction of inflammation.
This is important because reducing the cost and crucially time in the early stages
of compound development can have a disproportionate benefit in profitability in
a cycle that has a short patent lifetime. The aim of VS is to score, rank and/or
filter a set of chemical structures to ensure that those molecules with the highest
likelihood of activity are assayed first in a “lead discovery programme”[5].
The use of machine learning methods for VS has been widely studied. Tech-
niques such as artificial neural networks and support vector machines in addition
to more conventional approaches such as similarity matching and nearest neigh-
bour analysis have all been explored while little attention has been paid to the
use of FDA or its variants. An important recent development is the technique
of binary kernel discrimination (BKD) which produces scores based on the es-
timated likelihood ratio of active to inactive compounds that are then ranked.
The likelihoods are estimated through a Parzen Windows approach using the bi-
nomial distribution function (to accommodate binary descriptor or “fingerprint”
vectors representing the presence, or not, of certain substructural arrangements
of atoms) in place of the usual Gaussian choice [6]. This choice of kernel func-
tion uses Hamming distance but by substituting the Jaccard/Tanimoto distance
instead, additional active compounds can be retrieved [7]. We will use results
from BKD and its variant for comparison.
Virtual screening suffers strongly from the so-called small-sample-size prob-
lem where the number of covariates is comparable to or exceeds the number of
samples. Typically a task in VS comprises a sample of size O (102) of known
descriptors but with fingerprints of dimension O (103). Clearly some form of
complexity control is therefore necessary.
In this paper we again exploit the association of FDA with LS but control
complexity by penalizing the likelihood function. It is well-known that penalty
functions that induce sparsity lead to non-smooth formulations and these are tra-
ditionally solved via mathematical programming techniques [8]. In a departure,
we apply a minorize-maximize (MM) technique to overcome this technical prob-
lem leading to a very simple iterative algorithm that is guaranteed to converge
to the (penalized) maximum likelihood solution. In [9] a general MM framework
is presented for variable selection via penalized maximum likelihood but there
only a small LS problem in conjunction with the SCAD penalty is examined.
The paper is organized as follows. Section 2 briefly states the well-known link
between FDA and LS [1], presents the kernel-based formulation and motivates
the use of penalized maximum likelihood. The following section introduces the
MM principle and sketches a derivation of the iterative algorithm. Section 4
presents a performance comparison with other leading machine learning methods
on a well-studied set of benchmarks and the results of applying the proposed
method to VS are given in section 5.
2 Fisher Discriminant Analysis and its Variants
The relationship between FDA and LS is well known [1]. Consider the matrix
of m-dimensional sample vectors U = [u1,u2, . . . ,uN ] comprising two groups,
Gi, of size, ni, i = 1, 2 represented by the partition,
[
U1 U2
]
. Membership of G1
is denoted by yˆ = +n/n1 and of G2 by yˆ = −n/n2 then it is straightforward
to verify that the solution, ω =
[
b w
]T, to the following LS problem lies in the
same direction as the solution for the Fisher discriminant [1].
arg min
(b,w)
∥∥∥∥[ nn11n1− nn21n2
]
−
[
1n1 U1
1n2 U2
] [
b
w
]∥∥∥∥2
2
(1)
where 1p denotes a p-vector of ones.
To accommodate more complex discriminants, data can be mapped into a
new feature space, F , via some function, φ, say. However, vectors in F will
typically be of very high dimension precluding any practical manipulation. The
“kernel trick” recognizes that the coefficients, w, in the linear model implicit
in (1) can themselves be written as a linear combination of the mapped data,
leading to a formulation entirely based on inner products that can be com-
puted through the agency of a suitable kernel. These ideas have been explored
thoroughly elsewhere e.g. so we omit further exposition and simply present the
kernelized version of the LS problem (see e.g. [4] for details).
Let K denote the Gram matrix associated with the kernel, k(., .), i.e. kij =
k (ui,uj), i, j = 1, 2, . . . , N then the solution, ω =
[
b α
]T, to the following LS
problem provides the coefficients of a linear discriminant in the feature space
associated with k(., .) hence non-linear discrimination in the data space.
arg min
(b,α)
∥∥∥∥[ nn11n1− nn21n2
]
−
[
1n1 K1
1n2 K2
] [
b
α
]∥∥∥∥2
2
(2)
It is common to introduce a quadratic penalty into LS regression and this
can be interpreted in the Bayesian framework as placing a Gaussian prior on
the values of the coefficients. The quadratic penalty improves numerical condi-
tion when data are strongly correlated, militates against over-fitting and also
suggests a method for selecting variables – those with relatively small coeffi-
cient magnitudes can be discarded. Essentially, large deviations from zero are
strongly penalized while small values are only very lightly affected. Instead of
using a Gaussian penalty, a prior distribution with a sharp peak has the ef-
fect of penalizing non-zero coefficients much more strongly so that the pay-off
for setting small coefficients exactly to zero is relatively much greater. A log-
likelihood penalty of the form ‖ω‖qq 0 < q ≤ 1 has precisely this property. The
“sparsity-inducing” property of this penalty is well-known [2]. Introducing this
penalty leads to a difficulty in gradient-based optimization owing to its discon-
tinuous first derivative. Mathematical programming is the usually adopted to
address this but here we exploit the MM principle to provide a simple, iterative
algorithm.
3 Algorithm Development via the MM Principle
The MM principle seeks to replace a difficult optimization problem, in our case,
non-smooth, with a simpler (smooth) one having the same solution. In the case of
maximization, the idea is to find a non-unique surrogate function that minorizes
the objective function of interest and then to maximize this. Here we are able
to replace the non-smooth element of the likelihood function with a quadratic
function and then iterate toward the solution.
Let ω(n) denote the nth step in an iterative procedure, then a function,
S (ω|ω(n)), is said to minorize the function, ` (ω), if it is everywhere less than `
and is tangent to it at ω(n) e.g. [10]. Such a function that minorizes a concave
objective function can itself be maximized, often analytically, and this fact can
be exploited. The minorizing function, S(., .), acts as a surrogate for the original
objective function. The ascent property e.g. [10] guarantees that the value of ` (ω)
never decreases. The iteration will therefore converge to the global maximum
for a concave objective function. Minorization is closed under the operations of
addition and multiplication.
We outline the derivation of a very simple, Newton-like algorithm for the
penalized maximum likelihood estimation of the kFDA coefficients, c.f. [9]. The
log-likelihood function, ` (ω), is written as the sum of two functions, `e (ω) =
− 12‖yˆ − K˜ω‖22, and `p (ω) = −ρN‖ω‖qq, where yˆ =
[ n
n1
1n1
− nn21n2
]
∈ RN and K˜ =[
1N K
] ∈ RN×(N+1), giving:
` (ω) = −1
2
‖yˆ − K˜ω‖22 − ρN‖ω‖qq (3)
It is clear that in the case of interest, 0 < q ≤ 1, no closed-form solution exists
for the maximization of (3), however, by exploiting the fact that −|ω|q is convex
on R+ and −|ω|q = −
(
ω2
) q
2 it can be shown that `p (ω) is minorized at every
point, ω(n), by a quadratic function thus:
`p (ω) = −ρN‖ω‖qq ≥ −
ρ
2
N
i=d∑
i=1
(
qω2i
|ωi(n)|2−q + (2− q)|ωi(n)|
q
)
(4)
= −ρ
2
N
(
qωTB (ω(n))ω + (2− q)‖ω(n)‖qq
)
with B (ω(n)) = diag
{|ωi(n)|q−2}. The result arises from the relationship g(x) ≥
g(y) + dg(y)(x− y)∀x, y e.g. [10] and is ascribed to [11]. The function, ` (ω), in
equation (3) is therefore minorized when the RHS is replaced by the upper bound
given in (4) giving a quadratic surrogate having the ascent property:
S (ω|ω(n)) = ωTK˜Tyˆ − 1
2
ωT
(
K˜TK˜ + ρNqB (ω(n))
)
ω
(omitting constant terms), which can be maximized analytically w.r.t ω. Iden-
tifying ω(n+ 1) with ω and assuming ω(0) 6= 0 gives the following iteration
ω(n+ 1) =
(
K˜TK˜ + ρNqB (ω(n))
)−1
K˜Tyˆ (5)
A potential problem arises when the elements of ω(n) approach zero, as expected
when a sparse solution arises and S (ω|ω(n)) is no longer defined. Hunter and
Li [9] deal with this formally but here we avoid the difficulty by re-writing
B (ω(n)) = Ψ−2n with Ψn = diag
{
|ωi(n)| 2−q2
}
[12] leading to
ω(n+ 1) = Ψn
(
ΨnK˜TK˜Ψn + ρNqIN
)−1
ΨnK˜Tyˆ;ω(0) 6= 0 (6)
Convergence is declared when the relative change in the norm of the coefficient
vectors is less than some threshold, , and a coefficient is deemed to equal zero
if its magnitude, relative to the largest, is less than η. We denote the resulting
classifiers kFDAq.
4 Performance Comparison with Previous Methods
To evaluate the performance of kFDAq extensive experimentation has been
carried out on 13 datasets (http://ida.first.fraunhofer.de/projects/bench/) that
have been used to benchmark numerous machine learning techniques [3, 4, 13].
The methodology outlined in [4] was followed to allow direct comparisons with [3,
4, 13]. We examine two situations: classifiers are selected based on minimum mis-
classification rate (MCR) and on number of retained samples (NS) from amongst
the first five realizations. Each is then applied to all 100 test partitions.
Table 1 shows percentage mean MCR and number of retained samples (be-
low) calculated for the test sets for each of the 13 domains. We report kFDAq
for q ∈ {1, 0.5}, the better of the two methods proposed in [4] referred to as
kFDAOLS, and the current best results in [3, 13]. From Table 1, the kFDA1 clas-
sifier (selected on MCR) is more accurate than kFDAOLS and the best other
reported technique across all 13 domains. However, its sparseness is relatively
poor in 10 out of 13 cases. Choosing the kFDA1 classifier for sparseness gives
best MCR in 7 out of 13 cases and outperforms kFDAOLS in 9 out of 13. This
gives comparable sparseness to kFDAOLS in many cases but is much worse in a
few.
To encourage further sparseness, q is reduced to 0.5. Selecting on MCR, kFDA0.5
now exhibits highest accuracy in 8 out of 13 cases while achieving comparable
sparseness with kFDAOLS (excepting “Splice”). In the other five cases perfor-
mance is comparable with kFDAOLS but with greater levels of sparsity. Selecting
for sparsity even simpler models are frequently found with no substantial loss of
performance. Performance on “Splice” is now comparable, for instance.
While differences are not great, it is fair to say that kFDAq offers convincingly
competitive performance across a range of classification tasks.
5 Application to Virtual Screening
Here 11 different activity classes – domains in which molecules have been as-
sayed for activity – from the MDL Drug Data Report (MDDR) database are
Table 1. Comparison of mean misclassification rate and sparsity for the proposed
algorithm, kFDAq, kFDAOLS (F) [4], and the best algorithm from[3, 13]: Support
Vector Machine (N) , Regularized AdaBoost (H), conventional kFDA (), Sparse kFDA
() and Sparse kFDA with Linear Loss (♦). Bold – best, italic – sample size.
Database Published kFDAOLS kFDA1 kFDA0.5
Best (%) (%) MCR (%) NS (%) MCR (%) NS (%)
Banana 10.6±0.4 10.7±0.5 9.74±0.00 13.05±0.15 10.48±0.12 11.60±0.12
400 8.00 ♦ 7.25 14.25 5.75 5.75 2.25
B. Cancer 25.2±4.4 25.3±4.1 21.21±3.71 25.55±4.05 20.81±3.73 25.35±4.02
200 12.00  3.50 11.00 2.00 4.00 1.00
Diabetes 23.1±1.8 23.1±1.8 22.93±1.68 24.04±1.71 23.96±1.69 25.50±1.89
468 2.14 F 2.14 2.14 1.28 0.85 0.43
German 23.6±2.3 24.0±2.1 19.38±1.87 23.43±2.04 24.55±2.13 24.08±2.00
700 2.00  1.14 11.86 4.00 0.57 0.43
Heart 15.8±3.4 15.8±3.4 14.63±3.36 14.63±3.36 15.46±3.22 15.46±3.22
170 1.76 F 1.76 4.71 4.71 1.76 1.76
Image 2.7±0.6 2.8±0.6 1.10±0.56 2.19±0.58 1.95±0.44 1.95±0.44
1300 100.00 H 21.54 46.15 22.46 16.69 16.69
Ringnorm 1.5±0.1 1.6±0.1 1.41±0.03 1.52±0.03 1.70±0.04 1.70±0.04
400 6.00 ♦ 1.75 9.00 3.75 1.00 1.00
S. Flare 32.4±1.8 33.5±1.6 31.90±1.90 32.69±1.96 31.07±1.88 32.60±1.82
660 91.00 N 1.36 56.21 44.09 4.85 2.27
Splice 9.5±0.7 11.7±0.6 7.03±0.79 7.46±0.80 7.32±0.75 8.22±0.91
1000 100.00 H 33.00 78.20 64.40 72.90 34.70
Thyroid 4.2±2.1 4.5±2.4 2.88±1.59 3.72±1.54 1.53±1.16 3.83±1.77
140 100.00  16.43 10.00 9.29 8.57 1.43
Titanic 22.4±1.0 22.4±1.0 21.10±0.23 22.09±0.24 21.10±0.23 22.72±0.26
150 7.33 F 7.33 40.67 34.00 6.00 1.33
Twonorm 2.6±0.2 2.7±0.2 2.32±0.00 2.32±0.00 2.87±0.04 2.87±0.04
400 100.00  2.50 3.75 3.75 1.25 1.25
Waveform 9.8±0.8 10.0±0.4 9.46±0.13 10.01±0.13 10.10±0.15 12.23±0.13
400 100.00 H 3.50 7.75 5.00 1.50 0.75
used [14]. The MDDR database contains 1,024-dimensional fingerprints repre-
senting 102,514 known drugs and biologically relevant molecules collected from
patent literature, journals, meetings and congresses. The classes used here were
selected to reflect typical drug discovery projects for pharmaceutical companies.
A “binomial” kernel is used, kij = k (ui,uj) = λm−d(ui,uj) (1− λ)d(ui,uj)
where λ ∈ [0.5, 1.0] denotes the kernel “width” and m = 1024. d (ui,uj) is a
measure of the degree of dis-similarity between molecules i and j. In [7] the
Jaccard/Tanimoto (J/T) distance was found to offer substantial gains over the
conventional Hamming distance (HD) when used in BKD. Experiments show
that this is also the case for kFDAq so only results using this function are re-
ported. The experiment was run five times with different random data splits.
λ is identified by five-fold cross validation on the basis of sum of active rank
position, e.g. if all n1 active compounds are ranked in the first n1 positions, the
rank sum is minimal.
In table 2, the mean self-similarity provides a measure of the homogeneity of
each of the activity classes and is a useful way to compare design spreads and
coverage. It is usual in chemoinformatics applications to report the percentage
of the maximum possible number of active compounds ranked in the top 5% of
the ranked database. These are shown in Table 2 along with the percentage of
Table 2. Comparison of maximum percentage actives retrieved in top 5% of sample.
Index Activity Class Self-Similarity BKD kFDA1 kFDA0.5
Mean S.D. HD (%) J/T (%) J/T (%) J/T (%)
1 5HT3 Antagonists 0.351 0.116 90.19 93.88 91.32 90.61
150 76.00 57.87
2 5HT1A Agonists 0.343 0.104 86.77 88.28 83.98 82.10
166 66.87 51.21
3 5HTReuptake Inhibitors 0.345 0.122 69.47 73.62 64.89 65.08
72 81.39 71.67
4 D2 Antagonists 0.345 0.103 74.25 77.97 70.25 68.34
80 78.50 59.00
5 Renin Inhibitors 0.573 0.106 98.84 99.10 99.25 99.23
226 53.63 28.14
6 Angiotensin II AT1 Antagonists 0.403 0.101 98.77 97.43 99.27 99.22
190 55.16 30.11
7 Thrombin Inhibitors 0.419 0.127 94.04 94.02 93.77 92.74
162 59.63 41.11
8 Substance P Antagonists 0.399 0.106 91.86 93.70 90.74 90.38
250 62.16 54.32
9 HIV Protease Inhibitors 0.446 0.122 94.37 94.70 92.89 93.45
150 54.53 45.47
10 Cyclo-oxygenase Inhibitors 0.268 0.093 68.43 76.26 65.52 63.11
128 86.25 71.09
11 Protein Kinase C Inhibitors 0.323 0.142 78.92 81.23 71.16 62.95
92 84.57 39.57
retained features (below). Results from kFDAq and from BKD are presented.
It is clear that BKDJ/T is the leading contender in eight out of 11 cases but
delivers no sparsity, while BKDHD is most accurate in one. As before, we see
that kFDA1 is generally more accurate (9/11) than kFDA0.5 but is less sparse,
as expected. However, kFDAq only displays best accuracy in two cases but is
comparable (< ±3%) to BKDJ/T in four others. It is worth noting that kFDAq
delivers its best accuracy in the classes that are most homogeneous.
6 Conclusion
We have introduced an algorithm for the solution of the kFDA problem through
the application of the MM principle. We have demonstrated that it performs
as well as or better than a number of leading machine learning algorithms in
a substantial benchmark. We have then applied the method to a problem in
chemoinformatics but found that performance is generally worse than an im-
portant recent development in this field, BKD. However, operationally, a sparse
solution may still be of value since many commercial databases contain O (106)
samples and speed of recall can be an issue. Given that, ultimately, both tech-
niques rely on optimally chosen linear combinations of kernel functions, this
failure seems puzzling. Qualitatively, there is a significant difference between the
benchmark and the molecular data – the fingerprint samples suffer extremely
from the small-sample-size problem and this fact may account for the drop in
performance. This issue is to be addressed in the future.
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